229 related articles for article (PubMed ID: 9869372)
1. Determination of ivabradine and its N-demethylated metabolite in human plasma and urine, and in rat and dog plasma by a validated high-performance liquid chromatographic method with fluorescence detection.
Klippert P; Jeanniot JP; Polvé S; Lefèvre C; Merdjan H
J Chromatogr B Biomed Sci Appl; 1998 Nov; 719(1-2):125-33. PubMed ID: 9869372
[TBL] [Abstract][Full Text] [Related]
2. High-performance liquid chromatographic method for determination of DN-2327, a novel non-benzodiazepine anxiolytic, and/or its active metabolite in human plasma and urine.
Hussein Z; Chu SY; Granneman GR
J Chromatogr; 1993 Mar; 613(1):105-12. PubMed ID: 8096213
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous determination of ivabradine and its metabolites in human plasma by liquid chromatography--tandem mass spectrometry.
François-Bouchard M; Simonin G; Bossant ; Boursier-Neyret C
J Chromatogr B Biomed Sci Appl; 2000 Aug; 745(2):261-9. PubMed ID: 11043745
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a sensitive LC-MS/MS-ESI method for the determination of ivabradine in human plasma: application to a pharmacokinetic study.
Jiang J; Tian L; Huang Y; Li Y
Biomed Chromatogr; 2013 Dec; 27(12):1603-8. PubMed ID: 23798342
[TBL] [Abstract][Full Text] [Related]
5. High-throughput, semi-automated determination of a cyclooxygenase II inhibitor in human plasma and urine using solid-phase extraction in the 96-well format and high-performance liquid chromatography with post-column photochemical derivatization-fluorescence detection.
Matthews CZ; Woolf EJ; Lin L; Fang W; Hsieh J; Ha S; Simpson R; Matuszewski BK
J Chromatogr B Biomed Sci Appl; 2001 Feb; 751(2):237-46. PubMed ID: 11236079
[TBL] [Abstract][Full Text] [Related]
6. Sensitive method for the determination of KC 12291 in rat plasma and urine by high-performance liquid chromatography.
Tomori E; Tormási E; Varga M; Borlak J
J Chromatogr B Biomed Sci Appl; 1998 Jan; 705(1):105-10. PubMed ID: 9498676
[TBL] [Abstract][Full Text] [Related]
7. Determination of 1,3-di(4-imidazolino-2-methoxyphenoxy)propane in rat, dog and human plasma and urine by high-performance liquid chromatography with fluorescence detection.
Hanson GD; Slattum P; Tidwell RR; Bekersky I; Mong S
J Chromatogr; 1993 Dec; 622(1):61-9. PubMed ID: 8120114
[TBL] [Abstract][Full Text] [Related]
8. Quantitative determination of the novel anticancer drug E7070 (indisulam) and its metabolite (1,4-benzenedisulphonamide) in human plasma, urine and faeces by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
Beumer JH; Rosing H; Hillebrand MJ; Nan-Offeringa LG; Foley K; Yule SM; Heck AJ; Schellens JH; Beijnen JH
Rapid Commun Mass Spectrom; 2004; 18(23):2839-48. PubMed ID: 15517526
[TBL] [Abstract][Full Text] [Related]
9. [Effects of stable isotope labeled internal standard on determination of ivabradine and N-demethylivabradine in human plasma].
Liu DQ; Yu JH; Zhang YF; Zhong DF; He L; Chen XY
Yao Xue Xue Bao; 2015 Mar; 50(3):348-54. PubMed ID: 26118116
[TBL] [Abstract][Full Text] [Related]
10. Determination of mildronate in human plasma and urine by liquid chromatography-tandem mass spectrometry.
Lv YF; Hu X; Bi KS
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):35-9. PubMed ID: 17287154
[TBL] [Abstract][Full Text] [Related]
11. Quantitation of 4-cyclohexyl-2-hydroxy-3-(3-methylsulfanyl-2- [2-[(morpholine-4-carbonyl)amino]-3-phenylpropionylamino]propi onylamino ) butyric acid isopropyl ester (CP-80,794), a renin inhibitor, and its hydrolytic cleavage metabolite 2-[(morpholine-4-carbonyl)amino]-3-phenylpropionic acid (CP-84,364) in dog and human plasma by high-performance liquid chromatography.
Allen MC; Stafford CG; Nocerini MR
J Chromatogr B Biomed Sci Appl; 1997 Aug; 696(2):243-51. PubMed ID: 9323544
[TBL] [Abstract][Full Text] [Related]
12. High-performance liquid chromatographic-ultraviolet assay for the simultaneous quantitation of BMS-181101 and its putative hydroxy metabolites in rat and monkey plasma.
Shah VR; Srinivas NR; Campbell DA; Mantha S; Duncan G; Schuster A; Whigan DW; Shyu WC
Biomed Chromatogr; 1996; 10(3):135-8. PubMed ID: 8792865
[TBL] [Abstract][Full Text] [Related]
13. Determination of lefucoxib in rat plasma, urine, and feces by high-performance liquid chromatography with fluorescence detection: application in pharmacokinetic studies.
Bi X; Meng Z; Dou G
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):199-205. PubMed ID: 17161982
[TBL] [Abstract][Full Text] [Related]
14. Determination of NVP-BEZ235, a dual PI3K and mTOR inhibitor, in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography with fluorescence detection.
Lin F; Chandrasekaran G; de Gooijer MC; Beijnen JH; van Tellingen O
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jul; 901():9-17. PubMed ID: 22727754
[TBL] [Abstract][Full Text] [Related]
15. Determination of casopitant and its three major metabolites in dog and rat plasma by positive ion liquid chromatography/tandem mass spectrometry.
Ferrari L; Reami D; Michi M
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):2974-82. PubMed ID: 20870467
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of UHPLC-ESI-MS/MS method for the determination of selected cardiovascular drugs, polyphenols and their metabolites in human urine.
Magiera S; Baranowska I; Kusa J
Talanta; 2012 Jan; 89():47-56. PubMed ID: 22284458
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of a novel KDR kinase inhibitor and its N-oxide metabolite in human plasma using 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry.
Xu Y; Du L; Soli ED; Braun MP; Dean DC; Musson DG
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):287-96. PubMed ID: 15686997
[TBL] [Abstract][Full Text] [Related]
18. A validated, rapid UPLC-MS/MS method for simultaneous ivabradine, reboxetine, and metoprolol analysis in human plasma and its application to clinical trial samples.
Zoerner AA; Schroeder C; Kayacelebi AA; Suchy MT; Gutzki FM; Stichtenoth DO; Tank J; Jordan J; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():105-11. PubMed ID: 23434314
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of benazepril hydrochloride and benazeprilat in plasma by high-performance liquid chromatography/electrospray-mass spectrometry.
Xiao W; Chen B; Yao S; Cheng Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):303-8. PubMed ID: 15639452
[TBL] [Abstract][Full Text] [Related]
20. Sensitive and accurate liquid chromatography-tandem mass spectrometry methods for quantitative determination of a novel hepatitis C NS5B inhibitor BMS-791325 and its active metabolite in human plasma and urine.
Jiang H; Demers R; Kandoussi H; Burrell R; Eley T; Kadiyala P; Cojocaru L; Baker C; Ryan J; Aubry AF; Arnold ME; Zeng J
J Pharm Biomed Anal; 2015 Mar; 107():17-23. PubMed ID: 25562845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
